Connection

CHANDRA BARTHOLOMEUSZ to Ataxia Telangiectasia Mutated Proteins

This is a "connection" page, showing publications CHANDRA BARTHOLOMEUSZ has written about Ataxia Telangiectasia Mutated Proteins.
  1. Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer. Breast Cancer Res Treat. 2019 Jun; 175(2):339-351.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.